Priscila E Parra-Pingel, Luis A Quisiguiña-Avellán, Luis Hidalgo, Peter Chedraui, Faustino R Pérez-López
{"title":"患有严重子痫前期的年轻和年长青少年母亲的妊娠结局。","authors":"Priscila E Parra-Pingel, Luis A Quisiguiña-Avellán, Luis Hidalgo, Peter Chedraui, Faustino R Pérez-López","doi":"10.2147/AHMT.S131050","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Adolescent mothers are at higher risk for preeclampsia, but the effect of their age on the outcome of the pregnancy complication is not clear.</p><p><strong>Objective: </strong>To describe maternal and neonatal outcomes among singleton adolescent pregnancies complicated with severe preeclampsia in a low-income-setting hospital and compare results according to age.</p><p><strong>Materials and methods: </strong>Maternal and neonatal outcomes of 213 adolescent mothers complicated with severe preeclampsia delivering at the Enrique C. Sotomayor Obstetrics and Gynecology Hospital (Guayaquil, Ecuador) were analyzed and compared according to their age (16 or less years, n=82 vs 17-19 years, n=131).</p><p><strong>Results: </strong>Cesarean section rate was high in both studied groups; otherwise, obstetrical outcome did not differ and there were no maternal deaths or severe complications. Neonatal outcome was adverse in the two groups evidenced by high rates of preterm birth, small-for-gestational-age and low-birth-weight infants, low first-minute Apgar scores and admissions to neonatal intensive care; however, it was not significantly different between the analyzed groups. There were no neonatal deaths among mothers aged 16 or less and 4 in the group aged 17-19 years. This was, however, not significant (<i>p</i>=0.30).</p><p><strong>Conclusion: </strong>Pregnancy outcome in this adolescent population with severe preeclampsia was similarly adverse, independent of maternal age.</p>","PeriodicalId":46639,"journal":{"name":"Adolescent Health Medicine and Therapeutics","volume":"8 ","pages":"81-86"},"PeriodicalIF":1.7000,"publicationDate":"2017-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/AHMT.S131050","citationCount":"23","resultStr":"{\"title\":\"Pregnancy outcomes in younger and older adolescent mothers with severe preeclampsia.\",\"authors\":\"Priscila E Parra-Pingel, Luis A Quisiguiña-Avellán, Luis Hidalgo, Peter Chedraui, Faustino R Pérez-López\",\"doi\":\"10.2147/AHMT.S131050\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Adolescent mothers are at higher risk for preeclampsia, but the effect of their age on the outcome of the pregnancy complication is not clear.</p><p><strong>Objective: </strong>To describe maternal and neonatal outcomes among singleton adolescent pregnancies complicated with severe preeclampsia in a low-income-setting hospital and compare results according to age.</p><p><strong>Materials and methods: </strong>Maternal and neonatal outcomes of 213 adolescent mothers complicated with severe preeclampsia delivering at the Enrique C. Sotomayor Obstetrics and Gynecology Hospital (Guayaquil, Ecuador) were analyzed and compared according to their age (16 or less years, n=82 vs 17-19 years, n=131).</p><p><strong>Results: </strong>Cesarean section rate was high in both studied groups; otherwise, obstetrical outcome did not differ and there were no maternal deaths or severe complications. Neonatal outcome was adverse in the two groups evidenced by high rates of preterm birth, small-for-gestational-age and low-birth-weight infants, low first-minute Apgar scores and admissions to neonatal intensive care; however, it was not significantly different between the analyzed groups. There were no neonatal deaths among mothers aged 16 or less and 4 in the group aged 17-19 years. This was, however, not significant (<i>p</i>=0.30).</p><p><strong>Conclusion: </strong>Pregnancy outcome in this adolescent population with severe preeclampsia was similarly adverse, independent of maternal age.</p>\",\"PeriodicalId\":46639,\"journal\":{\"name\":\"Adolescent Health Medicine and Therapeutics\",\"volume\":\"8 \",\"pages\":\"81-86\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2017-06-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2147/AHMT.S131050\",\"citationCount\":\"23\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Adolescent Health Medicine and Therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/AHMT.S131050\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2017/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Adolescent Health Medicine and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/AHMT.S131050","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 23
摘要
背景:青少年母亲患先兆子痫的风险较高,但其年龄对妊娠并发症结局的影响尚不清楚。目的:描述低收入医院单胎青少年妊娠合并严重子痫前期的孕产妇和新生儿结局,并按年龄比较结果。材料与方法:对厄瓜多尔瓜亚基尔Enrique C. Sotomayor妇产医院213例合并重度子痫前期的少女母亲按年龄(16岁及以下,n=82 vs 17-19岁,n=131)分娩的母婴结局进行分析比较。结果:两组患者剖宫产率均较高;除此之外,产科结果没有差异,没有产妇死亡或严重并发症。两组新生儿预后不良,早产率高,胎龄小,出生体重低,第一分钟Apgar评分低,新生儿重症监护入院;然而,在分析组之间没有显著差异。16岁及以下的母亲中没有新生儿死亡,17-19岁年龄组中有4例新生儿死亡。然而,这并不显著(p=0.30)。结论:严重子痫前期青少年人群的妊娠结局同样不利,与母亲年龄无关。
Pregnancy outcomes in younger and older adolescent mothers with severe preeclampsia.
Background: Adolescent mothers are at higher risk for preeclampsia, but the effect of their age on the outcome of the pregnancy complication is not clear.
Objective: To describe maternal and neonatal outcomes among singleton adolescent pregnancies complicated with severe preeclampsia in a low-income-setting hospital and compare results according to age.
Materials and methods: Maternal and neonatal outcomes of 213 adolescent mothers complicated with severe preeclampsia delivering at the Enrique C. Sotomayor Obstetrics and Gynecology Hospital (Guayaquil, Ecuador) were analyzed and compared according to their age (16 or less years, n=82 vs 17-19 years, n=131).
Results: Cesarean section rate was high in both studied groups; otherwise, obstetrical outcome did not differ and there were no maternal deaths or severe complications. Neonatal outcome was adverse in the two groups evidenced by high rates of preterm birth, small-for-gestational-age and low-birth-weight infants, low first-minute Apgar scores and admissions to neonatal intensive care; however, it was not significantly different between the analyzed groups. There were no neonatal deaths among mothers aged 16 or less and 4 in the group aged 17-19 years. This was, however, not significant (p=0.30).
Conclusion: Pregnancy outcome in this adolescent population with severe preeclampsia was similarly adverse, independent of maternal age.
期刊介绍:
Adolescent Health, Medicine and Therapeutics is an international, peer reviewed, open access journal focusing on health, pathology, and treatment issues specific to the adolescent age group, including health issues affecting young people with cancer. Original research, reports, editorials, reviews, commentaries and adolescent-focused clinical trial design are welcomed. All aspects of health maintenance, preventative measures, disease treatment interventions, studies investigating the poor outcomes for some treatments in this group of patients, and the challenges when transitioning from adolescent to adult care are addressed within the journal. Practitioners from all disciplines are invited to submit their work as well as health care researchers and patient support groups. Areas covered include: Physical and mental development in the adolescent period, Behavioral issues, Pathologies and treatment interventions specific to this age group, Prevalence and incidence studies, Diet and nutrition, Specific drug handling, efficacy, and safety issues, Drug development programs, Outcome studies, patient satisfaction, compliance, and adherence, Patient and health education programs and studies.